ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.89
0.70%
US Tech 100
18,107.20
0.20%
S&P 500
5,303.27
0.12%
US Dollar vs CAD
1.36125
0.03%
Bitcoin
67,177.81
1.54%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. LianBio (LIAN)

  7. LianBio (LIAN) News

LIAN

LianBio (LIAN)

LianBio
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:LIAN
DateTimeSourceHeadlineSymbolCompany
03/11/20246:51AMEdgar (US Regulatory)Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securitiesNASDAQ:LIANLianBio
02/28/20246:00AMGlobeNewswire Inc.LianBio Announces Voluntarily Delisting from NasdaqNASDAQ:LIANLianBio
02/20/20243:10PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LIANLianBio
02/13/20246:04AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LIANLianBio
02/13/20246:00AMGlobeNewswire Inc.LianBio Announces Completion of Strategic ReviewNASDAQ:LIANLianBio
01/08/20245:13AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LIANLianBio
12/29/20236:56AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LIANLianBio
12/26/20233:10PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:LIANLianBio
12/26/20233:07PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LIANLianBio
12/26/20231:40PMAllPennyStocks.comBiotech Finds Success Following Holiday WeekendNASDAQ:LIANLianBio
12/26/20231:00AMGlobeNewswire Inc.LianBio Enters into Agreement Assigning its Rights for NBTXR3 in China and Other Asian MarketsNASDAQ:LIANLianBio
12/20/20237:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LIANLianBio
12/20/20237:00AMGlobeNewswire Inc.LianBio Announces Departure of Chief Financial OfficerNASDAQ:LIANLianBio
12/19/20233:26PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LIANLianBio
12/19/20233:05PMGlobeNewswire Inc.LianBio Announces Departure of Chief Executive OfficerNASDAQ:LIANLianBio
12/06/20233:23PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LIANLianBio
12/06/20233:05PMGlobeNewswire Inc.LianBio’s Board of Directors Unanimously Determines not to Pursue Unsolicited Proposal from Concentra BiosciencesNASDAQ:LIANLianBio
12/01/20233:16PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LIANLianBio
12/01/20233:05PMGlobeNewswire Inc.LianBio Confirms Receipt of Unsolicited Proposal from Concentra BiosciencesNASDAQ:LIANLianBio
11/13/20233:28PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LIANLianBio
11/13/20233:17PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LIANLianBio
11/13/20233:05PMGlobeNewswire Inc.LianBio Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:LIANLianBio
10/30/20233:16PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LIANLianBio
10/30/20233:05PMGlobeNewswire Inc.LianBio Announces Topline Results from Phase 3 LIBRA Trial of TP-03 in Chinese Patients with Demodex BlepharitisNASDAQ:LIANLianBio
10/25/20233:05PMGlobeNewswire Inc.LianBio Announces Presentation of Data from Phase 2a Study of Infigratinib in Patients with Gastric Cancer at ESMO Congress 2023NASDAQ:LIANLianBio
10/24/20239:25AMAllPennyStocks.comBiotech Shares Soar PremarketNASDAQ:LIANLianBio
10/24/20238:22AMDow Jones NewsLianBio Shares Soar Premarket on Strategic Review, End of Bristol PactNASDAQ:LIANLianBio
10/24/20235:59AMGlobeNewswire Inc.LianBio Enters into Agreement with Bristol Myers Squibb for Mavacamten in China and Other Asian MarketsNASDAQ:LIANLianBio
08/28/20233:05PMGlobeNewswire Inc.LianBio Announces Results from Phase 3 EXPLORER-CN Trial of Mavacamten Presented at the European Society of Cardiology Congress and Simultaneous Publication in JAMA CardiologyNASDAQ:LIANLianBio
08/14/20233:21PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LIANLianBio
 Showing the most relevant articles for your search:NASDAQ:LIAN

Your Recent History

TSXV
UN
Universal Ventures Inc.
COIN
TINCUST
Tiny Coin
USOTC
CCOZF
China Coal Energy (PK)
NYSE
OACB
Oaktree Acquisition Corp...
NASDAQI
FN45GI
First North Consumer Sta...
EU
ALCJ
Crossject
LATK
MRPHETH
Morpheus.Network
BOV
P1SA34R
PSA Operating REIT
BIT
EM35
ETF
BOV
CSNA3Q
SID NACIONAL ON
USOTC
GMVWF
G Medical Innovations (PK)
NYSE
CAAA
First Trust Exch
BIT
P1V223
NLBNPIT1V223 20991231 27...
NYSE
RMPL.PR
Rivernorth Marketplace Lending
USOTC
GMVHF
Entain (PK)
BIT
XLPS
Invesco Consumer Staples...
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved